Active Pharmaceutical Ingredient (API)

Palivizumab (RSV Prevention)

RSV Prophylaxis

Humanized monoclonal antibody for preventing severe RSV lung disease in premature infants.
Technical Profile
Reference Code
PAL659
CAS Number
188039-54-5
Chemical Class
N/A
Therapeutic Class
N/A

Verified Brands

Medicines containing Palivizumab (RSV Prevention) as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.